-
BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of human diseases
June 9, 2021 BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of […]
-
BioLamina and Cellaria will collaborate to make accurate cell models for drug screening
February 11, 2021 BioLamina and Cellaria will collaborate to make accurate cell models for drug screening One of the biggest […]
-
Biolamina and Spiber Technologies sign exclusive sales and marketing deal for unique Biosilk products
June 18, 2019 Biolamina and Spiber Technologies sign exclusive sales and marketingdeal for unique Biosilk products BioLamina has for the […]
-
BioLamina and Novo Nordisk partner to advance stem cell based therapies for three common medical conditions
May 16, 2018 BioLamina and Novo Nordisk partner to advance stem cell based therapies for three common medical conditions BioLamina […]
-
BioLamina and partners aim to develop new methods to differentiate unlimited amounts of NK-cells to fight cancer
November 7, 2018 BioLamina and partners aim to develop new methods to differentiate unlimited amounts of NK-cells to fight cancer […]
-
BioLamina announces an OEM partnership with Cellink for the development of biologically relevant bioink products for bioprinting
August 27, 2018 BioLamina announces an OEM partnership with Cellink for the development of biologically relevant bioink products for bioprinting […]
-
Photo gallery
Photo gallery